MAOA inhibitor has been applied to multiple synergistic therapeutic strategies: Simon K P Schmich et al. [80] proposed MAOA expression with pancreatic ductal adenocarcinoma-related muscle wasting and the therapeutic potential of the MAOA inhibition with harmine hydrochloride. This evidence concerns the gene MAOA and pancreatic ductal adenocarcinoma.